Trade Amarin Corporation plc - AMRN CFD
Add to favourite- Summary
- Historical Data
Spread | 0.0163 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024151% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001929% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 0.5191 |
Open | 0.5104 |
1-Year Change | -34.51% |
Day's Range | 0.4895 - 0.5115 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 26, 2024 | 0.4900 | -0.0126 | -2.51% | 0.5026 | 0.5128 | 0.4772 |
Nov 25, 2024 | 0.5191 | -0.0151 | -2.83% | 0.5342 | 0.5456 | 0.5144 |
Nov 22, 2024 | 0.5422 | 0.0158 | 3.00% | 0.5264 | 0.5561 | 0.5114 |
Nov 21, 2024 | 0.5158 | 0.0344 | 7.15% | 0.4814 | 0.5208 | 0.4814 |
Nov 20, 2024 | 0.4759 | -0.0127 | -2.60% | 0.4886 | 0.4897 | 0.4659 |
Nov 19, 2024 | 0.4904 | 0.0209 | 4.45% | 0.4695 | 0.5085 | 0.4567 |
Nov 18, 2024 | 0.4592 | -0.0279 | -5.73% | 0.4871 | 0.4916 | 0.4489 |
Nov 15, 2024 | 0.4958 | -0.0152 | -2.97% | 0.5110 | 0.5115 | 0.4880 |
Nov 14, 2024 | 0.5138 | -0.0353 | -6.43% | 0.5491 | 0.5586 | 0.5046 |
Nov 13, 2024 | 0.5664 | 0.0268 | 4.97% | 0.5396 | 0.5777 | 0.5396 |
Nov 12, 2024 | 0.5448 | -0.0035 | -0.64% | 0.5483 | 0.5546 | 0.5312 |
Nov 11, 2024 | 0.5539 | -0.0079 | -1.41% | 0.5618 | 0.5722 | 0.5478 |
Nov 8, 2024 | 0.5671 | 0.0037 | 0.66% | 0.5634 | 0.5788 | 0.5602 |
Nov 7, 2024 | 0.5695 | -0.0257 | -4.32% | 0.5952 | 0.5952 | 0.5688 |
Nov 6, 2024 | 0.5887 | -0.0298 | -4.82% | 0.6185 | 0.6186 | 0.5775 |
Nov 5, 2024 | 0.6149 | 0.0115 | 1.91% | 0.6034 | 0.6277 | 0.5880 |
Nov 4, 2024 | 0.5989 | 0.0283 | 4.96% | 0.5706 | 0.6136 | 0.5694 |
Nov 1, 2024 | 0.5746 | 0.0078 | 1.38% | 0.5668 | 0.5986 | 0.5668 |
Oct 31, 2024 | 0.5724 | -0.0061 | -1.05% | 0.5785 | 0.5965 | 0.5495 |
Oct 30, 2024 | 0.5974 | -0.0190 | -3.08% | 0.6164 | 0.6235 | 0.5939 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Amarin Corporation plc Company profile
Amarin Corporation (AMRN) is a clinical-stage biopharmaceutical company focused on the commercialisation and improvement of therapeutics to cure and deal with cardiovascular diseases.
Established in 1989, Amarin is headquartered in Dublin, Ireland, and operates in several European countries, the United States, Canada, Lebanon and the United Arab Emirates.
The company’s lead commercial product VASCEPA (icosapent ethyl) is a prescription-only omega-3 fatty acid product. Taken as an adjunct to diet, it reduces triglyceride levels in adult patients suffering from severe hypertriglyceridemia. The drug helps to address cardiovascular risk for millions of patients.
VASCEPA was launched in the United States in 2013, but gained wider recognition in 2019 as the US Food and Drug Administration (FDA) approved Amarin for a broader indication for cardiovascular risk reduction in studied high-risk patients. It has also got approval from the European Commission to reduce the risks for cardiac patients.
Amarin still prices VASCEPA at a considerably lower level than other new drugs of its category.
Formerly known as Ethical Holdings, the company changed its name to Amarin Corporation in 1999. The company went public in July 2019. It trades on the Nasdaq under the ticker ‘AMRN’.
Industry: | Bio Therapeutic Drugs |
First Floor, Block 3, The Oval,
Shelbourne Road, Ballsbridge
DUBLIN
IE
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com